Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C391961-20 20 µg (0.2 mg/ml) $371 
LS-C391961-100 100 µg (0.2 mg/ml) $574 
MAGEA1 / MAGE 1 Antibody - Formalin-fixed, paraffin-embedded human testicular carcinoma stained with MAGE-1 antibody (MZ2E/838).  This image was taken for the unmodified form of this product. Other forms have not been tested.

Monoclonal Mouse anti‑Human MAGEA1 / MAGE 1 Antibody (clone MAAZ2, IHC, IF) LS‑C391961

Monoclonal Mouse anti‑Human MAGEA1 / MAGE 1 Antibody (clone MAAZ2, IHC, IF) LS‑C391961

Antibody:
MAGEA1 / MAGE 1 Mouse anti-Human Monoclonal (MAAZ2) Antibody
Application:
IHC, IHC-P, IF
Reactivity:
Human
Format:
Unconjugated, Unmodified
Price
Catalog Number
$371
LS-C391961-20
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
MAGEA1 / MAGE 1 Mouse anti-Human Monoclonal (MAAZ2) Antibody
Application:
IHC, IHC-P, IF
Reactivity:
Human
Format:
Unconjugated, Unmodified

Specifications

Description
MAGE 1 antibody LS-C391961 is an unconjugated mouse monoclonal antibody to human MAGE 1 (MAGEA1). Validated for IF and IHC.
Target
Human MAGEA1 / MAGE 1
Synonyms
MAGEA1 | Antigen MZ2-E | Cancer/testis antigen 1.1 | CT1.1 | MAGE-1 antigen | MAGE1A | Melanoma antigen family A 1 | Melanoma antigen MAGE-1 | MAGE 1 | MAGE1 | Melanoma-associated antigen 1
Host
Mouse
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
IgG1,k Monoclonal
Clone
MAAZ2
Conjugations
Unconjugated
Purification
Protein G purified
Modifications
Unmodified. Also available Ready-to-Use, Azide-free, BSA-free.
Immunogen
Recombinant human MAGEA1 protein.
Specificity
Human MAGEA1 / MAGE 1
Applications
  • IHC
  • IHC - Paraffin (1 - 2 µg/ml)
  • Immunofluorescence (1 - 2 µg/ml)
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
Usage
The MAGE family of genes codes an important group of antigens. It was identified that melanomas and primary glial brain tumors express common melanoma associated antigens (MAAs). Because MAGE-1 is expressed on a significant proportion of human neoplasms of various histological types (melanoma, brain tumors of glial origin, neuroblastoma, non-small cell lung cancer, breast, gastric, colorectal, ovarian, renal cell carcinomas) and not on normal tissues, the encoded antigen may serve as a marker of early detection and target for cancer immunotherapy. Optimal dilution of the MAGE-1 antibody should be determined by the researcher. Staining of formalin-fixed tissues requires boiling tissue sections in 10mM citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 min.
Presentation
1X PBS, 0.1 mg/ml BSA, 0.05% sodium azide
Storage
Store at 2°C to 8°C.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About MAGEA1 / MAGE 1
P43355 NM_004988 NP_004979.3

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/26/2024